Ranitidine (Zantac) returns

Jack summarizes ranitidine's 2019 withdrawal for NDMA, reformulation, and its renewed place among H2 blockers.

Play episode from 01:41

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!